Large volume paracentesis: Is there a limit?

IF 3.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Alejandro Tovar-Duran, Carlos A. Campoverde-Espinoza, Fatima Higuera-De la Tijera, Jose L. Pérez-Hernández
{"title":"Large volume paracentesis: Is there a limit?","authors":"Alejandro Tovar-Duran,&nbsp;Carlos A. Campoverde-Espinoza,&nbsp;Fatima Higuera-De la Tijera,&nbsp;Jose L. Pérez-Hernández","doi":"10.1016/j.aohep.2025.101844","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction and Objectives</h3><div>Ascites is observed in 5-10% of cirrhotic patients. Large volume paracentesis (LVP), where &gt;5 liters are drained, is safe. Albumin is essential to prevent post-paracentesis circulatory dysfunction (PPCD), with the literature indicating that its incidence increases when draining &gt;8 liters in one session, suggesting draining a smaller amount.</div></div><div><h3>Materials and Patients</h3><div>An observational, analytical, and retrospective study was conducted, which included the clinical records of patients over 18 years of age admitted to the Gastroenterology service of the General Hospital of Mexico \"Dr. Eduardo Liceaga\" from January 2020 to March 2024 with a diagnosis of Grade II or III ascites, without criteria for acute kidney injury (AKI) according to the International Ascites Club (ICA) and with baseline creatinine available in the last 3 months before assessment. The amount of ascites that were drained was evaluated, with no limit of liters in a session, and the occurrence of AKI during the following 7 days after paracentesis as a manifestation of PPCD. The definition of AKI was according to the latest definition by KDIGO / ICA. We excluded patients admitted with a diagnosis of AKI or a history of chronic kidney disease (CKD) of any etiology, and those in whom it was not specified whether albumin was administered after paracentesis. Descriptive statistics were performed with measures of central tendency and dispersion. We used X2, Student's T test, and Mann-Whitney U test to compare the variables. A value of <em>P &lt; 0.05</em> was considered statistically significant.</div></div><div><h3>Results</h3><div>We included 60 patients with a diagnosis of cirrhosis, administered for grade II and grade III ascites, 53.3% were men, with an overall mean age of 51.1 ±10.5 years. Regarding the etiology, 45% were due to alcohol, 21.7% to Fatty Liver Disease Associated with Metabolic Dysfunction (MASLD), as well as the etiology of no filiation; with MELD-Na 17.5 ± 5.7 points. Regarding ascites, 26.7% were grade II and 73.3% grade III, and up to 10% with refractory ascites. The average of liters of ascites drained per session was 8.5 ± 3.8 liters, with a minimum drainage of 5 liters and a maximum of 19.4 liters per session. Of the total patients evaluated, 5% (3) developed AKI after paracentesis, with an elevation of creatinine &gt; 0.3 mg/dl in 48 hours. When comparing groups regarding the presence of ACLF, Child-Pugh, or MELD-Na; Regarding the DPPC, 41.66% (0%) drained less than 8 liters vs 58.34% (8.57%) more than 8 liters, all with refractory ascites, with no significant difference in the development of AKI (p=&gt;0.05).</div></div><div><h3>Conclusions</h3><div>LVP is safe as long as the albumin dose is adequately replaced at a dose of 6-8 grams per liter of drained ascites in a single session, with caution in patients with refractory ascites, due to the advanced stage of portal hypertension.</div></div>","PeriodicalId":7979,"journal":{"name":"Annals of hepatology","volume":"30 ","pages":"Article 101844"},"PeriodicalIF":3.7000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of hepatology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1665268125000687","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction and Objectives

Ascites is observed in 5-10% of cirrhotic patients. Large volume paracentesis (LVP), where >5 liters are drained, is safe. Albumin is essential to prevent post-paracentesis circulatory dysfunction (PPCD), with the literature indicating that its incidence increases when draining >8 liters in one session, suggesting draining a smaller amount.

Materials and Patients

An observational, analytical, and retrospective study was conducted, which included the clinical records of patients over 18 years of age admitted to the Gastroenterology service of the General Hospital of Mexico "Dr. Eduardo Liceaga" from January 2020 to March 2024 with a diagnosis of Grade II or III ascites, without criteria for acute kidney injury (AKI) according to the International Ascites Club (ICA) and with baseline creatinine available in the last 3 months before assessment. The amount of ascites that were drained was evaluated, with no limit of liters in a session, and the occurrence of AKI during the following 7 days after paracentesis as a manifestation of PPCD. The definition of AKI was according to the latest definition by KDIGO / ICA. We excluded patients admitted with a diagnosis of AKI or a history of chronic kidney disease (CKD) of any etiology, and those in whom it was not specified whether albumin was administered after paracentesis. Descriptive statistics were performed with measures of central tendency and dispersion. We used X2, Student's T test, and Mann-Whitney U test to compare the variables. A value of P < 0.05 was considered statistically significant.

Results

We included 60 patients with a diagnosis of cirrhosis, administered for grade II and grade III ascites, 53.3% were men, with an overall mean age of 51.1 ±10.5 years. Regarding the etiology, 45% were due to alcohol, 21.7% to Fatty Liver Disease Associated with Metabolic Dysfunction (MASLD), as well as the etiology of no filiation; with MELD-Na 17.5 ± 5.7 points. Regarding ascites, 26.7% were grade II and 73.3% grade III, and up to 10% with refractory ascites. The average of liters of ascites drained per session was 8.5 ± 3.8 liters, with a minimum drainage of 5 liters and a maximum of 19.4 liters per session. Of the total patients evaluated, 5% (3) developed AKI after paracentesis, with an elevation of creatinine > 0.3 mg/dl in 48 hours. When comparing groups regarding the presence of ACLF, Child-Pugh, or MELD-Na; Regarding the DPPC, 41.66% (0%) drained less than 8 liters vs 58.34% (8.57%) more than 8 liters, all with refractory ascites, with no significant difference in the development of AKI (p=>0.05).

Conclusions

LVP is safe as long as the albumin dose is adequately replaced at a dose of 6-8 grams per liter of drained ascites in a single session, with caution in patients with refractory ascites, due to the advanced stage of portal hypertension.
大容量穿刺:有限制吗?
介绍和目的在5-10%的肝硬化患者中观察到腹水。大容量穿刺(LVP)是安全的,其中抽取5升。白蛋白对预防穿刺后循环功能障碍(PPCD)至关重要,文献表明,当一次引流8升时,其发生率增加,建议减少引流量。材料和患者进行了一项观察性、分析性和回顾性研究,其中包括2020年1月至2024年3月在墨西哥总医院“Dr. Eduardo Liceaga”消化科就诊的18岁以上诊断为II级或III级腹水的患者的临床记录。没有根据国际腹水俱乐部(ICA)的急性肾损伤(AKI)标准,并且在评估前3个月有基线肌酐。评估排空腹水的数量,每次不限制公升,以及在穿刺后7天内AKI的发生作为PPCD的表现。AKI的定义是根据KDIGO / ICA的最新定义。我们排除了诊断为AKI或有任何病因的慢性肾脏疾病(CKD)病史的患者,以及未明确在穿刺后是否给予白蛋白的患者。描述性统计采用集中趋势和离散度测量。我们使用X2、Student's T检验和Mann-Whitney U检验来比较变量。P <的值;0.05认为有统计学意义。结果我们纳入60例诊断为肝硬化的患者,治疗II级和III级腹水,53.3%为男性,总体平均年龄51.1±10.5岁。在病因方面,45%为酒精所致,21.7%为脂肪性肝病伴代谢功能障碍(MASLD)所致,且无发病原因;MELD-Na为17.5±5.7分。关于腹水,26.7%为II级,73.3%为III级,高达10%为难治性腹水。平均每次排水量为8.5±3.8升,每次排水量最小为5升,最大为19.4升。在所有评估的患者中,5%(3)在穿刺后发生AKI,肌酐升高;48小时内0.3 mg/dl。当比较各组ACLF、Child-Pugh或MELD-Na的存在时;DPPC排水量小于8升的占41.66%(0%),大于8升的占58.34%(8.57%),均为难治性腹水,AKI的发生无显著差异(p=>0.05)。结论slvp是安全的,只要白蛋白剂量以每升排空腹水6-8克的剂量在一次治疗中充分替换,对于难治性腹水患者,由于门静脉高压的晚期,要谨慎。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Annals of hepatology
Annals of hepatology 医学-胃肠肝病学
CiteScore
7.90
自引率
2.60%
发文量
183
审稿时长
4-8 weeks
期刊介绍: Annals of Hepatology publishes original research on the biology and diseases of the liver in both humans and experimental models. Contributions may be submitted as regular articles. The journal also publishes concise reviews of both basic and clinical topics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信